Literature DB >> 7621771

Automatic auditory discrimination is impaired in Parkinson's disease.

E Pekkonen1, V Jousmäki, K Reinikainen, J Partanen.   

Abstract

Deviant tones embedded in a sequence of standard tones elicit an event-related potential (ERP) component called the mismatch negativity (MMN), which reflects automatic stimulus change detection in the human auditory system. To determine whether stimulus change detection is impaired in Parkinson's disease (PD), we recorded ERPs in 13 non-demented patients with PD and in 11 age-matched healthy control subjects both when tones were attended and when they were unattended. The difference area between deviant and standard ERPs was used to evaluate the MMN in the 'unattended' condition. The MMN was significantly smaller in patients with PD than in controls. In the attended condition, the amplitudes of both N1 and the N2 complex were smaller in the patient group than in controls. MMN attenuation suggests that PD patients have impaired automatic stimulus change detection compared with healthy controls. This might be caused by dopamine deficiency in PD.

Entities:  

Mesh:

Year:  1995        PMID: 7621771     DOI: 10.1016/0013-4694(94)00304-4

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  14 in total

1.  Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a "rhythm disorder"?

Authors:  Sabine Skodda; Andrea Flasskamp; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2010-03-18       Impact factor: 3.575

2.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

3.  Altered N100-potential associates with working memory impairment in Parkinson's disease.

Authors:  Tua Annanmaki; Kirsi Palmu; Kari Murros; Juhani Partanen
Journal:  J Neural Transm (Vienna)       Date:  2017-07-14       Impact factor: 3.575

4.  Nonhuman primate model of schizophrenia using a noninvasive EEG method.

Authors:  Ricardo Gil-da-Costa; Gene R Stoner; Raynard Fung; Thomas D Albright
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 5.  N200 and P300 component changes in Parkinson's disease: a meta-analysis.

Authors:  Hui Xu; Lihua Gu; Shiyao Zhang; Yuchen Wu; Xiaojin Wei; Caiyan Wang; Yuhan Xu; Yijing Guo
Journal:  Neurol Sci       Date:  2022-08-18       Impact factor: 3.830

6.  Mismatch negativity-like potential (MMN-like) in the subthalamic nuclei in Parkinson's disease patients.

Authors:  Eduard Minks; Pavel Jurák; Jan Chládek; Jan Chrastina; Josef Halámek; Daniel J Shaw; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2014-05-09       Impact factor: 3.575

7.  Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects.

Authors:  Andres H Neuhaus; Terry E Goldberg; Youssef Hassoun; John A Bates; Katharine W Nassauer; Serge Sevy; Carolin Opgen-Rhein; Anil K Malhotra
Journal:  Schizophr Res       Date:  2009-04-07       Impact factor: 4.939

8.  The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study.

Authors:  Milena Korostenskaja; Dubravko Kicić; Seppo Kähkönen
Journal:  Psychopharmacology (Berl)       Date:  2008-02-09       Impact factor: 4.530

9.  Identification of TAAR5 Agonist Activity of Alpha-NETA and Its Effect on Mismatch Negativity Amplitude in Awake Rats.

Authors:  Aleksander A Aleksandrov; Veronika M Knyazeva; Anna B Volnova; Elena S Dmitrieva; Olga Korenkova; Stefano Espinoza; Andrey Gerasimov; Raul R Gainetdinov
Journal:  Neurotox Res       Date:  2018-05-01       Impact factor: 3.911

Review 10.  The mismatch negativity: a review of underlying mechanisms.

Authors:  Marta I Garrido; James M Kilner; Klaas E Stephan; Karl J Friston
Journal:  Clin Neurophysiol       Date:  2009-01-31       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.